" /> Bioavailability - CISMeF





Preferred Label : Bioavailability;

NCIt related terms : Drug Bioavailability;

NCIt definition : The rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action (21CFR320.1).;

Alternative definition : CDISC-GLOSS: Rate and extent to which a drug is absorbed or is otherwise available to the treatment site in the body.; CDISC: The rate and extent to which the active drug ingredient or therapeutic moiety is absorbed from a drug product and becomes available at the site of drug action. (US FDA 21 CFR 320.1);

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
01/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.